Baxter International Inc
NYSE:BAX

Watchlist Manager
Baxter International Inc Logo
Baxter International Inc
NYSE:BAX
Watchlist
Price: 28.57 USD 2.62%
Market Cap: 14.7B USD

BAX's latest stock split occurred on Jul 1, 2015

The company executed a 1841-for-1000 stock split, meaning that for every 1000 shares held, investors received 1841 new shares.

Before the split, BAX traded at 69.9396 per share. Afterward, the share price was about 33.4643.

The adjusted shares began trading on Jul 1, 2015. This was BAX's 5th stock split, following the previous one in May 31, 2001.

Last Splits:
Jul 1, 2015
1841-for-1000
May 31, 2001
2-for-1
Dec 1, 1992
100000-for-90823
Nov 18, 1983
2-for-1
Nov 9, 1981
2-for-1
Pre-Split Price
32.7151 69.9396
Post-Split Price
33.4643
Before
After
Last Splits:
Jul 1, 2015
1841-for-1000
May 31, 2001
2-for-1
Dec 1, 1992
100000-for-90823
Nov 18, 1983
2-for-1
Nov 9, 1981
2-for-1

Baxter International Inc
Stock Splits History

BAX Stock Splits Timeline
Jul 1, 2015
Jul 1, 2015
Split 1841-for-1000
x1.841
Pre-Split Price
32.7151 69.9396
Post-Split Price
33.4643
Before
After
May 31, 2001
May 31, 2001
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
14.1796
Before
After
Dec 1, 1992
Dec 1, 1992
Split 100000-for-90823
x1.101042687425
Pre-Split Price
N/A
Post-Split Price
14.1796
Before
After
Nov 18, 1983
Nov 18, 1983
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
14.1796
Before
After
Nov 9, 1981
Nov 9, 1981
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
14.1796
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 7, 2025
BioNexus Gene Lab Corp
NASDAQ:BGLC
1-for-10
/10
0.235 2.35 USD 2.92 2.92 USD
Apr 7, 2025
Alligator Bioscience AB
STO:ATORX
1-for-1000
/1000
0.0055 5.5 SEK 5.4 5.4 SEK
Apr 7, 2025
Treasure Global Inc
NASDAQ:TGL
1-for-50
/50
0.057 2.85 USD 2.8 2.8 USD
Apr 7, 2025
S
Safe & Green Development Corp
NASDAQ:SGD
105-for-100
x1.05
1.28 1.219 USD 1.14 1.14 USD
Apr 7, 2025
G
Ge-Shen Corporation Bhd
KLSE:GESHEN
959692-for-319897
x3.0000031260062
4.35 1.45 MYR 1.37 1.37 MYR
Load More

Baxter International Inc
Glance View

Economic Moat
None
Market Cap
14.6B USD
Industry
Health Care

Baxter International Inc. finds its roots in the early 1930s, a time when the healthcare landscape was vastly different. Founded by Donald Baxter, a medical doctor seeking to improve the quality and safety of intravenous therapy, the company initially focused on researching and developing safe ways to provide patients with sterile intravenous solutions. As the years unfolded, Baxter transformed itself from a small operation into a globally recognized healthcare giant. Today, it operates in the realm of lifesaving medical products and services, specializing in the development of essential pharmaceuticals, clinical nutrition for hospitals, advanced kidney care solutions, and critical care technology that healthcare providers depend on daily. Central to Baxter's business model is its commitment to innovation and improving patient outcomes, which drives its success and profitability. By leveraging its expertise in areas like renal and hospital products, Baxter is able to cultivate a diversified portfolio. This diversification not only helps the company mitigate risks but also strengthens its market position. Revenue streams are generated through the manufacture and sale of medical devices and pharmaceuticals, catering mostly to hospitals, clinics, and renal care centers worldwide. Baxter consistently reinvests in its research and development, aiming to pioneer novel therapies and products that address the evolving needs of the healthcare sector, ensuring that it remains a key player in the ongoing story of medical progress.

BAX Intrinsic Value
46.05 USD
Undervaluation 38%
Intrinsic Value
Price
Back to Top